Cheah, C. Y., Chihara, D., Horowitz, S., Sevin, A., Oki, Y., Zhou, S., . . . Fanale, M. A. (2016). Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes. Ann Oncol.
Chicago ZitierstilCheah, C. Y., et al. "Patients With Classical Hodgkin Lymphoma Experiencing Disease Progression After Treatment With Brentuximab Vedotin Have Poor Outcomes." Ann Oncol 2016.
MLA ZitierstilCheah, C. Y., et al. "Patients With Classical Hodgkin Lymphoma Experiencing Disease Progression After Treatment With Brentuximab Vedotin Have Poor Outcomes." Ann Oncol 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.